Transcenta Holding Limited (Transcenta) released an announcement dated 28 August 2026 detailing the current composition of its Board of Directors and the membership of its three key board committees.

The Board now comprises six directors: one executive director, two non-executive directors and three independent non-executive directors. Dr. Xueming Qian serves as both Chief Executive Officer and Chairman and is the sole executive director. Non-executive directors are Dr. Li Xu and Dr. Han Sen Xu. Independent non-executive directors include Mr. Jiasong Tang, Ms. Helen Wei Chen and Prof. Genhong Cheng.

Committee assignments are structured as follows: • Audit Committee – Chaired by Mr. Jiasong Tang, with Dr. Li Xu and Dr. Han Sen Xu as members. • Remuneration Committee – Chaired by Ms. Helen Wei Chen, with Mr. Jiasong Tang serving as a member. • Nomination Committee – Chaired by Dr. Xueming Qian; Mr. Jiasong Tang and Ms. Helen Wei Chen act as members.

The announcement provides an up-to-date overview of Transcenta’s governance framework, identifying clear leadership roles across the Board and its committees.